MORGAN STANLEY PLC/CALL/STRYKER CORP./450/0.1/20.12.24 Share Price

Warrant

DE000ME9BQE6

Market Closed - Börse Stuttgart 19:09:22 14/05/2024 BST
0.155 EUR -3.73% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./450/0.1/20.12.24
Current month-35.60%
1 month-54.00%
Date Price Change
14/05/24 0.155 -3.73%
13/05/24 0.161 -11.54%
10/05/24 0.182 -2.15%
09/05/24 0.186 +1.09%
08/05/24 0.184 -2.13%

Delayed Quote Börse Stuttgart

Last update May 14, 2024 at 07:09 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME9BQE
ISINDE000ME9BQE6
Date issued 27/02/2024
Strike 450 $
Maturity 20/12/2024 (220 Days)
Parity 10 : 1
Emission price 0.56
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.73
Lowest since issue 0.155
Spread 0.036
Spread %18.95%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
324.6 USD
Average target price
372.4 USD
Spread / Average Target
+14.73%
Consensus